ZEISS Webinar

Use of fluorescence in neurovascular procedures aided by Robotic Visualization System

Use of fluorescence in neurovascular procedures aided by Robotic Visualization System

Three leading Neurosurgeons will discuss the use of fluorescence in neurovascular procedures using the KINEVO® 900 from ZEISS. You will hear personal experiences of our speaker panelists on how the use of innovative visualization technologies can enable various vascular procedures and how the use of hybrid visualization platforms can assist in the advancement of the practice of vascular neurosurgery.

Date & Time:

Friday, July 10, 2020 | 1:00 PM – 2:00 PM (PDT) / 4:00 PM – 5:00 PM (EDT)

About the Speakers:

Dr. Michael Lawton is the President and CEO of Barrow Neurological Institute and the Chair of the Department of Neurosurgery. He is board certified by the American Board of Neurological Surgery.

Dr. Lawton’s neurosurgical expertise includes cerebrovascular disorders (aneurysms, arteriovenous malformations, cavernous malformations, and stroke) and skull base tumors. He has experience in treating nearly 5,000 brain aneurysms, more than 900 AVMs, and 1,000 cavernous malformations, including more than 250 in the brain stem and other highly delicate areas of the brain. He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, Society of Neurological Surgeons, American Academy of Neurological Surgery, and World Academy of Neurological Surgery.

Dr. Lawton received a degree in biomedical engineering from Brown University and his medical degree from Johns Hopkins University School of Medicine. He completed his neurosurgery residency at Barrow, where he also completed a fellowship in cerebrovascular and skull base surgery. After joining the faculty at University of California, San Francisco, he later completed a fellowship in endovascular surgery there.

Dr. Lawton’s research studies the formation, underlying genetics, and rupture of brain AVMs, as well as the hemodynamics, rupture, and computational modeling of brain aneurysms. His clinical research studies the anatomy of microsurgical approaches and clinical outcomes of microsurgery for aneurysms, AVMs, and bypass surgery. He is the principal investigator for the Brain Vascular Malformation Consortium, a NIH-funded multicenter group studying the genetics and clinical course of rare vascular diseases of the brain. He has published over 450 peer-reviewed articles, three single-author textbooks, and over 70 book chapters. He co-founded Mission: BRAIN, a teaching mission to raise the level of neurosurgery practiced in developing countries that conducts annual missions in Mexico and Asia.

Michael T. Lawton, MD
President and CEO; Professor and Chair, Neurosurgery; Chief, Neurovascular Surgery, Barrow Neurological Institute

Jonathan J. Russin, MD
Assistant Professor of Clinical Neurological Surgery; Associate Surgical Director, USC Neurorestoration Center; Director, Cerebrovascular Surgery at the University of Southern California

Dr. Jonathan J. Russin is an assistant professor of neurological surgery at the University of Southern California, Los Angeles, the Director of Cerebrovascular Surgery and Associate Director of the Center for Neurorestoration.

He holds a Bachelor of Science and Master of Humanities from Drew University, Madison NJ. Dr. Russin received his medical degree from New Jersey Medical School, the University of Medicine and Dentistry of New Jersey, graduating as a member of the Alpha Omega Alpha medical honor society.

He completed his internship in general surgery and residency in neurosurgery at the University of Southern California. He holds a fellowship in cerebrovascular and skull base neurosurgery from the Barrow Neurosurgical Institute.

Dr. Russin is board certified by the American Board of Neurological Surgeons, a member of the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS), and the AANS/CNS Joint Cerebrovascular Section. He is currently on the program committee for the CV/SNIS joint 2020 meeting, has served as editor of the Joint CV Section website and bypass course director for the CNS and AANS.

He is independently funded by the NIH and has contributed to numerous peer-reviewed publications on a variety of clinical topics.

Dr. Gary Steinberg is the Chair of Neurosurgery at Stanford University, Director of the Stanford Moyamoya Center, and the Founder and Co-Director of the Stanford Stroke Center. As a cerebrovascular and skull base neurosurgeon, he specializes in treating brain aneurysms, moyamoya disease, brain and spinal AVMs and other vascular malformations, carotid artery disease, meningiomas, skull base tumors and stroke. He has received many prestigious honors including the Society of Neurological Surgeons H. Richard Winn, M.D. Prize and the Smithsonian American Ingenuity Award.

Dr. Steinberg has practiced neurosurgery at Stanford for 33 years. He has pioneered microsurgical techniques to repair intracranial vascular malformations and certain aneurysms that were previously considered untreatable. He has also refined revascularization techniques for patients with cerebrovascular arterial occlusions, including moyamoya disease. Dr. Steinberg's lab investigates pathomechanisms of cerebral ischemia and develops innovative approaches such as stem cell transplantation and optogenetic stimulation to enhance post-stroke functional recovery. He is leading novel clinical trials of stem cell therapy for stroke and spinal cord injury.

Gary K. Steinberg, MD, PhD
Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and the Neurosciences; Chair, Department of Neurosurgery, Stanford University School of Medicine

Register for the Webinar

The statements of the speakers reflect only their personal opinions and do not necessarily reflect the opinions of any institution with which they are affiliated. The speakers have a contractual or other financial relationship with Carl Zeiss Meditec, Inc. and its affiliates and have received financial support.